Cardiology
Acute Myocarditis
Recognition (post-viral, autoimmune, drug-induced), cardiac MRI, supportive care, biopsy if fulminant, escalation pathway.
Source: ESC 2013 Myocarditis Position; AHA 2020
Step 1 of ~6
info
Recognise
Variable presentation: chest pain mimicking ACS (typical of viral), HF (acute or subacute), arrhythmia, sudden cardiac death. Often preceded by viral prodrome 1–4 weeks. Triggers: viral (Coxsackie, parvovirus B19, HHV-6, CMV, EBV, SARS-CoV-2, HIV), bacterial, autoimmune (SLE, sarcoid, eosinophilic), drug-induced (clozapine, ICI cancer immunotherapy), post-vaccine (rare).
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Glasdegib (Specialist drug) · Hedgehog pathway inhibitor
- Vismodegib (Specialist drug) · Hedgehog pathway (SMO) inhibitor
- Phenylephrine · Alpha-1 Adrenergic Agonist (Pure Vasoconstrictor)
- Methylene Blue · Guanylate Cyclase / Nitric Oxide Pathway Inhibitor
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Lisinopril (HFrEF / Post-MI) · ACE Inhibitor / HFrEF
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only. Always apply local guidelines and clinical judgement.